USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fertin Pharma A/S

USPTO PatentsView assignee record - 44 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Fertin ranks #7,407 of 49,997 tracked US assignees by granted-patent volume, with 44 patents across 12 technology areas.

#7,407
of 49,997 US assignees by volume
Top 27%
by Innovation Score (43.9/100)
20.4
avg claims per patent
+123%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7407 · Foreign Corporation #7,407 · 44 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 44 grants
  • UPPER-Q #7,407/49,997
  • PHOTO-FINISH Fastcap Systems
  • CPC-FOCUS A61K · 12 areas
  • INNOV-PAR 43.9/100
  • CLAIMS-DENSE 20.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +123% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Fastcap Systems Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fertin’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Fertin

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Fertin's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Fertin?

Each dot is one of Fertin’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fertin’s own 20.4 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Fertin vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 43.944.044.04444.044.044.1 510152025 Granted patents (volume) Avg claims / patent Fastcap Systems Corporation - 44, 22.36Fastcap SystemsFujifilm North America Corporation - 44, 23.66Fujifilm North Am…Faurecia Emissions Control Technologies, Germany GmbH - 44, 17.16Faurecia Emission…Femasys Inc. - 44, 11.75FemasysFette Compacting GmbH - 44, 13.11Fette CompactingGD Midea Environment Appliances MFG Co., Ltd. - 44, 8.82GD Midea Environm…GE Healthcare BioProcess R&D AB - 44, 19.91GE Healthcare Bio…Goal Zero LLC - 44, 8.36Goal ZeroFertin Pharma A/S - 44, 20.39Fertin Pharma A/S
Fertin vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fertin's grants concentrate

Fertin Pharma A/S is a focused PatentsView assignee: 12 CPC subclasses with 97.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (10 grants) versus a trough of 2 in 2017. By volume, Fertin sits between Fastcap Systems Corporation and Goal Zero LLC.

Fertin's three-year grant acceleration

Fertin Pharma A/S shows 16 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Fertin's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Fertin holds 44 patents at rank #7,408, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Fertin

By rank, the assignees closest to #7,408 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Fertin's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fertin, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Fertin ranks #519 of 7,163 assignees by patent count in that subclass.

Fertin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 2015201620172019202020212022202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Fertin Pharma A/S patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 9.1%
2016 3 6.8%
2017 2 4.5%
2019 4 9.1%
2020 3 6.8%
2021 10 22.7%
2022 4 9.1%
2023 5 11.4%
2024 7 15.9%
2025partial year 2 4.5%

Which technologies does Fertin Pharma A/S patent most?

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Fertin Pharma A/S's patent record in context - here's where to go next.

  • Fertin Pharma A/S's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 97.7% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #7,407 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Fertin Pharma A/S against Fastcap Systems Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.